Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-23-000013
Filing Date
2023-08-08
Accepted
2023-08-08 16:02:13
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20230630.htm   iXBRL 10-Q 1080246
2 EX-3.2 exhibit32_secondamendedand.htm EX-3.2 102495
3 EX-10.2 amicuswuxisupplyagreementr.htm EX-10.2 293645
4 EX-31.1 fold-06302023xex311.htm EX-31.1 11057
5 EX-31.2 fold-06302023xex312.htm EX-31.2 11130
6 EX-32.1 fold-06302023xex321.htm EX-32.1 8555
12 image_0a.jpg GRAPHIC 7836
  Complete submission text file 0001178879-23-000013.txt   6246357

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20230630.xsd EX-101.SCH 31515
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20230630_cal.xml EX-101.CAL 66565
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20230630_def.xml EX-101.DEF 130176
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20230630_lab.xml EX-101.LAB 575134
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20230630_pre.xml EX-101.PRE 350733
63 EXTRACTED XBRL INSTANCE DOCUMENT fold-20230630_htm.xml XML 779238
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 231151081
SIC: 2834 Pharmaceutical Preparations